Market capitalization | $858.06m |
Enterprise Value | $823.63m |
EV/Sales (TTM) EV/Sales | 14.07 |
P/S ratio (TTM) P/S ratio | 14.66 |
Dividend yield | 12.39% |
Last dividend (FY24) | $2.04 |
Revenue growth (TTM) Revenue growth | -41.73% |
Revenue (TTM) Revenue | $58.53m |
EBIT (operating result TTM) EBIT | $184.95m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
Sep '24 |
+/-
%
|
||
Revenue | 59 59 |
42%
42%
|
|
Gross Profit | 48 48 |
46%
46%
|
|
EBITDA | 185 185 |
228%
228%
|
EBIT (Operating Income) EBIT | 185 185 |
228%
228%
|
Net Profit | 185 185 |
228%
228%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.
Head office | United States |
Founded | 1986 |
Website | www.teklacap.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.